The Jeffrey Epstein files reveal the convicted child sex offender was fascinated by magicians, and detail a years-long relationship between Blaine as well as an ...

On Feb. 10, pharmaceutical company Moderna announced that the FDA Center for Biologics Evaluation and Research (CBER) had refused to review its application to market an investigational mRNA-based flu ...

The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine, mRNA-1010. The company said the agency’s justification for refusing a review is inconsistent with ...

The Federal Trade Commission sent a letter to Tim Cook one day after President Trump circulated a report raising questions ...

This week, many high school seniors who applied early decision II are hearing whether they were admitted, deferred to the ...

Thousands of families have planned their lives around current rules,” reads the letter, posted on social media.

The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for ...

The move signals an escalation in the agency’s efforts to interfere with established procedures for testing and approving vaccines.

Moderna’s mRNA-1010 was expected to contribute $1 billion to the company’s coffers by 2028. That plan is now out the window ...

Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share ...

Earn 2% to 5% cash back on everyday purchases with this no-annual-fee three-card combo. See how to simplify and maximize rewards in 2026.

Moderna said its new flu shot has been cleared for review in Australia, Canada and the European Union. It has asked to meet ...